Abstract This work describes the step-by-step development of a novel, serum-free, in vitro cell culture system resulting in the formation of robust, contracting, multinucleate myotubes from dissociated skeletal muscle cells obtained from the hind limbs of fetal rats. This defined system consisted of a serum-free medium formulation developed by the systematic addition of different growth factors as well as a nonbiological cell growth promoting substrate, N-1[3-(trimethoxysilyl) propyl] diethylenetriamine. Each growth factor in the medium was experimentally evaluated for its effect on myotube formation. The resulting myotubes were evaluated immunocytochemically using embryonic skeletal muscle, specifically the myosin heavy chain antibody. Based upon this analysis, we propose a new skeletal muscle differentiation protocol that reflects the roles of the various growth factors which promote robust myotube formation. Further observation noted that the proposed skeletal muscle differentiation technique also supported muscle-nerve coculture. Immunocytochemical evidence of nerve-muscle coculture has also been documented. Applications for this novel culture system include biocompatibility and skeletal muscle differentiation studies, understanding myopathies, neuromuscular disorders, and skeletal muscle tissue engineering.
Introduction
The goal of this study was to develop a serum-free cell culture model to study and understand skeletal muscle differentiation and to better understand the process by which individual skeletal muscle cells migrate and align in order to form functional, contractile, multinucleated myotubes (Li and Olson 1992; Olson 1992a, b; Olson and Perry 1992; Schwarz et al. 1992; Arnold and Winter 1998; BrandSaberi and Christ 1999; Scaal et al. 1999; Brand et al. 2000; Christ and Brand-Saberi 2002; Brand-Saberi 2005) . The serum-free cell culture model required the development of a medium, which was supplemented with different growth factors and utilized a synthetic biocompatible silane substrate for cell growth. We formulated the serum-free medium by systematically studying the effects of individual growth factors on myotube formation in vitro.
In vivo and in vitro studies carried out in the previous two decades have indicated that skeletal muscle differentiation involves the specific interaction of multiple growth factors with both the myocytes and, subsequently, the developing myotubes. The different growth factors implicated in skeletal muscle differentiation include vitronectin, basic fibroblast growth factor (bFGF), cardiotrophin-1 (CT1), glial cell linederived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF), neurotrophin (NT)3, and NT4 (Li and Olson 1992; Olson 1992a, b; Olson and Perry 1992; Schwarz et al. 1992; Arnold and Winter 1998; Brand-Saberi and Christ 1999; Scaal et al. 1999; Brand et al. 2000; Christ and BrandSaberi 2002; Hornik et al. 2004 ; ) However, no systematic in vitro study had been carried out that combined these different growth factors in order to develop a defined medium. In this study, the effects of bFGF, CT1, GDNF, BDNF, NT3, NT4, and vitronectin on myocyte fusion and skeletal muscle differentiation were analyzed. Through this analysis, a simple chemical-and growth factor-based medium formulation was developed and a novel technique, which promoted the formation of robust, functional, contractile, multinucleated myotubes in culture, was proposed. Immunocytochemical characterization was performed on the different myotube morphologies using embryonic myosin heavy chain (MHC) antibody (F1.652). Preliminary reports documented the enhanced myotube formation as well as their integration on silicon microstructures but not the mechanism of myotube formation (Das et al. 2006 (Das et al. , 2007b . This technique, which promoted robust myotube formation, was also observed to support nerve-muscle coculture (Das et al. 2007a ). Immunocytochemical evidences of the muscle-nerve coculture were also established. We believe that this chemically defined formulation and the proposed mechanistic development model will be useful tools in studying myocyte biocompatibility, muscle differentiation, myopathies, muscle tissue engineering, and neuromuscular junction formation.
Materials and Methods
Surface modification. Glass coverslips (Thomas Scientific, Swedesboro, NJ, 6661F52, 22×22 mm No.1) were cleaned using an O 2 plasma cleaner (Harrick, Ossining, NY, PDC-32G) for 20 min at 100 mTorr. The N-1 [3-(trimethoxysilyl) propyl] diethylenetriamine (DETA; United Chemical Technologies Inc., Lewistown, PA, T2910 KG) films were formed by the reaction of the cleaned surface with a 0.1% (v/v) mixture of the organosilane in freshly distilled toluene (Fisher, Pittsburgh, PA, T2904). The DETA-coated coverslips were heated to just below the boiling point of the toluene, rinsed with toluene, reheated to just below the boiling temperature, and then oven dried Das et al. 2007b ).
Surface characterization. Surfaces were characterized by contact angle measurements using an optical contact angle goiniometer (KSV Instruments, Monroe, CT, Cam 200) and X-ray photoelectron spectroscopy (XPS; Kratos Axis 165, Manchester, UK). XPS survey scans, as well as highresolution N1s and C1s scans, utilizing monochromatic Al Kα excitation, were obtained (Ravenscroft et al. 1998; Das et al. 2006) .
Skeletal muscle culture and serum-free medium. The skeletal muscle was dissected from the thighs of the hind limbs of fetal rats (17-18 d old). The tissue was collected in a sterile 15 ml centrifuge tube containing 1 ml of phosphate-buffered saline (calcium-and magnesium-free; Gibco, Grand Island, NY, 14200075). The tissue was enzymatically dissociated using 1 ml of 0.05% of trypsinethylenediaminetetraacetic acid (Gibco 25300054) solution for 30 min in a 37°C water bath (100 rpm). After 30 min, the trypsin solution was removed and 2 ml of L15 + 10% fetal calf serum (Gibco, 16000044) was added to terminate the trypsin action. The tissue was then mechanically triturated. The supernatant was then transferred to a 15-ml centrifuge tube. The same process was repeated two more times by adding 2 ml of L15 + 10% fetal bovine serum each time. The 6-ml cell suspension obtained after mechanical trituration was suspended on a 2-ml 4% bovine serum albumin (BSA; Sigma, St. Louis, MO, A3059; prepared in L15 medium) cushion and centrifuged at 300×g for 10 min at 4°C. The pellet obtained was washed five times with L15 medium, then resuspended in 10 ml of L15, and plated on 100 mm uncoated dishes for 30 min. The nonattached cells were removed, centrifuged on a 4% BSA cushion, and plated on the coverslips. The cells were plated at a density of 700-1,000 cells/mm 2 . The cells attached to the substrate in 1 h. The serum-free medium (containing different formulations of growth factors) was added to the culture dish after 1 h and the cells were maintained in a 5% CO 2 incubator (relative humidity 85%). Half of the medium was changed every 4 d (Das et al. 2007b) .
Three cell types coculturing in the defined medium. For coculturing of the skeletal muscle, dissociated sensory neurons (DRG), and spinal cord neurons, a simple coculture technique was developed. The dissociated muscle cells were mixed with DRG and the spinal cord cells. The DRG isolation protocol was described in an earlier paper (Liu et al. 2008) . In brief, DRGs were isolated from embryonic day 14 (E14) rat embryos and dissociated using trypsin. The resulting single cell suspension was then mixed with the dissociated muscle cells in the serum-free medium. Similarly, the whole spinal cord was removed from E14 embryos and dissociated in a trypsin solution. Subsequently, the single cell suspension of the spinal cord cells was combined with the dissociated muscle/DRG cell suspension mixture. The combined three cell suspension was then plated on the coverslips at a density of 800 cells/mm 2 . After 30 min, the well containing coverslips were filled with serum-free medium (Fig. 1) . The first medium change was done at day 4 as described in Fig. 1 and the cultures were maintained for 3 wk.
Immunocytochemistry of skeletal muscle. Coverslips were prepared for immunocytochemical analysis as previously described (Das et al. 2007b) . Briefly, coverslips were rinsed with phosphate buffered saline (PBS), fixed in −20°C methanol for 5-7 min, washed in PBS, incubated in PBS supplemented with 1% BSA and 0.05% saponin (permeabilization solution) for 10 min, and blocked for 2 h with 10% goat serum and 1% BSA. Cells were incubated overnight with primary antibodies against embryonic myosin heavy chain (F1.652; Developmental Studies Hybridoma Bank, Iowa City, IA) diluted (1:5) in the blocking solution. Cells were washed with PBS and incubated with the secondary antibody (Cy3 conjugated antimouse, Jackson ImmunoResearch Labs, West Grove, PA, 1:200 dilution in PBS) for 2 h. After 2 h, the coverslips were rinsed with PBS and mounted on glass slides and observed under a confocal microscope.
Immunocytochemistry of cocultures double stained with neurofilament 150 and embryonic myosin heavy chain antibodies. Cocultures were processed for immunocytochemistry as described above. Next, cells were incubated overnight at 4°C with rabbit antineurofilament M polyclonal antibody, 150 kD (AB1981, diluted 1:2,000; Millipore/Chemicon, Temecula, CA), and fetal MHC (F1.652, IgG, Developmental Studies Hybridoma Bank, diluted 1:5). After incubating overnight, the coverslips were rinsed three times with PBS and incubated again with the appropriate secondary antibodies for 2 h. After rinsing three times in PBS, the coverslips were mounted with Vectashield_DAPI mounting medium onto the glass slides. The coverslips were visualized and images collected using a confocal microscope (UltraVIEW™ LCI, PerkinElmer, Boston, MA). Controls without primary antibody were negative.
AChR labeling of the myotubes. AChRs were labeled as described previously (Dutton et al. 1995) by incubating cultures with 5×10 −8 M of α-bungarotoxin, Alexa Fluor® 488 conjugate (B-13422; Invitrogen/Molecular Probes, Carlsbad, CA) for 1.5 h at 37°C before observation. Following incubation in α-bungarotoxin, the cultures were fixed as mentioned above for further staining with embryonic myosin heavy chain (F1.652) antibodies.
Results
DETA surface modification and characterization. Static contact angle and XPS analysis was used for validation of the surface modifications and for monitoring the quality of the surfaces. Stable contact angles (40.64°±2.9/mean ± standard deviation) throughout the study indicated a high reproducibility and quality of the DETA coatings and were similar to previously published results (Stenger et al. 1992; Hickman et al. 1994; Spargo et al. 1994; Schaffner et al. 1995; Ravenscroft et al. 1998; Das et al. 2003 Das et al. , 2006 . Based on the ratio of the N (401 and 399 eV) and the Si 2p 3/2 peaks, XPS measurements indicated that a complete monolayer of DETA was formed on the coverslips.
Development of serum-free medium formulation. The results have been summarized in Table 1 . Below the effects of the different growth factors present in the nine different formulations are discussed. Unless otherwise stated, half of the medium was changed every 3 to 4 d. Formulation I (F I) was the basal medium. It consisted of Leibovitz's medium and M199 in a 3:1 ratio (v/v). The basal medium did not promote myotube formation and the cells died after 4 d in culture.
In formulation II (F II), vitronectin was added to the basal medium. Myotube formation was not observed and cells did not survive in the culture for more than 4 d.
In formulation III (F III), B27 supplement was added to F II. The cells survive for 8-10 d, but there was no myotube formation.
In formulation IV (F IV), bFGF was added to F III. The addition of bFGF led to the formation of robust myotubes. Myotubes started appearing by day 2 in culture. Contracting myotubes were observed by day 4. Myotubes covered 50% of the total area of the coverslip and they survived for 10-12 d in culture. Many of the myotubes popped off of the coverslip due to extensive contractions. Extensive proliferation of fibroblasts in the culture was also observed.
In formulation V (F V), CT1 was added to F III. The addition of CT1 led to the formation of small myotubes with four to six nuclei. Myotubes started appearing by day 2 in culture and by day 4 most of these small myotubes showed mild contractions. Contractile myotubes covered 10% of the total area of the coverslips and the myotubes survived for 6-7 d in culture. The Formulation V had no bFGF in it. Small myotube formation was observed even without the presence of bFGF.
In formulation VI (F VI), both bFGF and CT1 were added to the F III. Robust myotube formation with a reduction in fibroblast proliferation was observed. Fibroblast proliferation was less compared to F IV where only bFGF was added. Contractile myotubes covered 60% of the total surface area of the coverslips. Most of the myotubes began contracting by day 4 and exhibited extensive contractions as well as surviving for 10-12 d in culture.
In formulation VII (F VII), GDNF and BDNF were added to F VI. Robust myotube formation as well as a significant reduction in fibroblast proliferation was observed. The presence of GDNF and BDNF significantly reduced fibroblast proliferation and increased the total surface area covered with myotubes. Almost 65% of the total surface area of the coverslip was covered with contractile myotubes. Most of the myotubes began to show contractions by day 4.
In formulation VIII (F VIII), NT3 and NT4 were added to F VII. No significant qualitative difference from F VII F formulation number indicating the components added in the medium, + factor had been added, Φ component had been omitted, L15 Leibovitz's medium, Vt vitronectin, B27 B27 supplement, bFGF basic fibroblast growth factor, CT1 cardiotrophin-1, BDNF brain-derived neurotrophic factor, GDNF glial derived neurotrophic factor, NT3 neurotrophin 3, NT4 neurotrophin 4, (-) no myotube formation, (− +) no myotube formation but cells survive for 8-10 d, (+) small myotubes consisting of four to six nuclei, (+++) robust myotube formation (ten to 30 nuclei), but with many fibroblasts that proliferated in the culture, (±±±) robust myotube formation (ten to 30 nuclei) with a reduction in fibroblast proliferation, (±±±±) robust myotube formation (ten to 30 nuclei) and a significant reduction in fibroblast proliferation, (±±±±±) robust myotube formation (ten to 30 nuclei), minimal fibroblast proliferation and further supports nerve-muscle coculture was observed. Functionally, the myotubes started contracting by day 2. Additionally, a significantly reduced fibroblast proliferation was observed compared to F III. In formulation IX (F IX), no additional growth factors were added; instead, two changes were made in the growth factor application. First, instead of replacing half of the medium during the first change, the entire medium was replaced. Second, in the process of changing the whole medium, bFGF was withdrawn, which resulted in the following formulation: neurobasal/vitronectin/B27/CT1/ GDNF/BDNF/NT3/NT4. These two changes brought about a significant increase in the total number of myotubes formed. The final medium formulation has been enumerated in Table 2 and the medium change protocol is represented in Fig. 1 . By day 6, 90% of the total surface area of the coverslip was covered with robust contractile myotubes. Additionally, there was minimal fibroblast contamination. Contractions began by day 2. The myotubes survived in culture for 16-20 d. All the different morphologies of myotubes observed in the culture were stained with embryonic myosin heavy chain antibodies ( Fig. 2A-D) . Chain-like ( Fig. 2A) , branched (Fig. 2B) , spindle-shaped (Fig. 2C) , and cylinder-like (Fig. 2D ) morphologies of myotubes were observed in the culture. The clustering of acetylcholine receptors on the membrane surface of the different myotube morphologies are shown in Fig. 1E-H . All of the myotubes showed clustering of acetylcholine receptors on their membrane surface.
Medium formulation IX (F IX) and the subsequent change at day 4 further supported the nerve-muscle coculture (Fig. 3A-F) . In Fig. 3A , the sensory neurons along with the myotubes in the cultures are shown. The sensory neurons were seen as large cell bodies. In Fig. 3B , the neuron processes run parallel to the mytotubes. In Fig. 3C , multipolar cell morphologies of motoneurons, along with the large sensory neurons, were detected. In Fig. 3D , branched, striated myotubes, and a neuronal process crossing over a myotube are noted. In Fig. 3E-F , the wrapping of a neuronal process on a myotube is represented in three dimensions.
Discussion
In this study, a step-by-step process was described to develop a novel, serum-free, in vitro cell culture system which results in the formation of robust, contracting, multinucleate myotubes from dissociated skeletal muscle cells that were obtained from the hind limbs of fetal rats. The step-by-step development consisted of experimentally evaluating the effect of individual growth factors on myocyte survival and subsequent myotube formation. At the conclusion of the study, the most optimal formulation, i.e., formulation IX (F IX), was shown to support muscle as well as nerve-muscle coculture growth. This serum-free medium supporting the survival, proliferation, and fusion of fetal rat myoblasts into contractile myotubes. The rational for selecting these growth factors (vitronectin, B27, bFGF, CT1, GDNF, BDNF, NT3, and NT4) was based solely upon the distribution of their receptors within the developing myotubes in the rat fetus.
Role of vitronectin. Vitronectin was added to the culture medium because its receptors promote cell adhesion and provide an anchoring function during the skeletal muscle differentiation process in vitro (Biesecker 1990; Gullberg et al. 1995) . The addition of vitronectin by itself did not promote myotube formation.
Role of B27. As previously documented, B27 supplement had supported cardiomyocyte growth (Das et al. 2004 Table 2 . Composition of novel serum-free medium for a 500-ml sample this culture medium, B27 supplement was added to the medium as a serum replacement. Although the addition of B27 supplement promoted cell survival, it did not promote myotube formation.
Role of bFGF and the controversy concerning the role of bFGF in differentiation. Basic fibroblast growth factor (FGF-2) is a 17-kDa member of the heparin binding growth factors. bFGF plays a complex, yet poorly understood, role in skeletal muscle differentiation. Several studies have indicated that bFGF promoted limb development, and some in vitro studies indicate that bFGF promotes the division of skeletal muscle cells, but inhibits the differentiation process. It had been documented that the terminal differentiation of the skeletal muscle occurs in the G1 phase but is repressed by fibroblast growth factor (Clegg et al. 1987; Burgess and Maciag 1989; Alterio et al. 1990; Gonzalez et al. 1990; Morrow et al. 1990; Anderson et al. 1991; Moore et al. 1991; Hannon et al. 1996; Ohuchi and Noji 1999; Nugent and Iozzo 2000) . Interestingly, in this study, even in the presence of bFGF, most myoblasts fused and differentiated to form functional myotubes. These in vitro results support the hypothesis that there are at least two different pools of myoblasts present in the developing limb bud. In one population, bFGF promotes differentiation and in the other it inhibits muscle differentiation.
Role of CT1. Cardiotrophin-1 is a cytokine belonging to the interleukin-6 family. It is expressed at high levels in the embryonic limb bud development and secreted by differentiated myotubes. CT1 promotes cardiac myocyte survival, regeneration of extraocular muscle, exhibits increased immunoreactivity in regenerating muscle, and promotes motoneuron survival (Sheng et al. 1996; Peroulakis and Forger 2000; Bordet et al. 2001; Dolcet et al. 2001; Mitsumoto et al. 2001; Oppenheim et al. 2001; Lesbordes et al. 2002; Chen and von Bartheld 2004; Nishikawa et al. 2005) . In this study, the addition of CT1 to basal medium/vitronectin/B27 was observed to promote the formation of small myotubes. This indicated that CT1 by itself has the potential to initiate myotube formation, but it needs support from other growth factors. Role of GDNF and BDNF. The glial cell line-derived neurotrophic factor is a glycosylated disulfide-bonded homodimer that is a distantly related member of the transforming growth factor-beta superfamily. GDNF plays a role in the differentiation and survival of central and peripheral neurons as well as in kidney organogenesis. GDNF is widely expressed in the development of skeletal muscle and is involved in regulating the distribution of acetylcholine receptors in mouse, primary skeletal muscle cells (Lin et al. 1993; Henderson et al. 1994; ChoiLundberg and Bohn 1995; Golden et al. 1999; Yang and Nelson 2004 ). Brain-derived neurotrophic factor is a ligand for the low-affinity nerve growth factor (NGF) receptor, p75, and for the high affinity neurotrophin receptor, trkB. It is expressed in the developing skeletal muscle, promotes motoneuron survival, and also plays a vital role in the formation of the neuromuscular junction. BDNF rescues myosin, heavy chain, IIB muscle fibers after neonatal nerve injury (Heinrich 2003; Simon et al. 2003; Mousavi et al. 2004 ) and along with NT4 promotes phenotypic recovery of both fast and slow twitch fibers. We believe that the aforementioned effects of GDNF and BDNF promote enhanced myotube formation in culture.
Role of NT3 and NT4. Neurotrophin-3 is a neurotrophic factor in the NGF family of neurotrophins. It is one of five neurotrophin growth factors which shape the development of the nervous system by regulating neuronal survival and differentiation (Oakley et al. 1997) . Recent studies have indicated that NT3 has an essential nonneuronal function. It plays a key role in cardiac development (Donovan et al. 1996) . NT4 (Carrasco and English 2003; Heinrich 2003; Simon et al. 2003) promotes the normal development of slow muscle fiber phenotypes and phenotypic recovery of fast and slow twitch fibers. Previously, studies in this lab indicated that the addition of NT3 and NT4 results in early contractions in the myotubes (Das et al. 2006) . Speculation is that the NT3 and NT4 have a synergistic effect in muscle differentiation.
Coculture studies. One interesting feature of the differential application of growth factors in formulation IX (F IX) was that it supported the survival and growth of skeletal muscle, sensory neurons, and spinal cord motoneurons in a three cell coculture model. While this seems intuitive, it is a crucial finding for easily building functional muscle-motoneuron, muscle-sensory neuron, and muscle-motoneuron-sensory neuron constructs and for ultimately reconstructing the stretch reflex arc in vitro.
This work documents the development of a medium formulation that resulted in robust myotube formation and provided an analysis of the role of the individual factors and their mechanism of action in that process. Furthermore, the myotubes developed a MHC profile, which resulted in functional contractile properties. The final medium formulation was determined to support the growth of motoneur- ons and sensory neurons as well as their coculture with myotubes. Consequently, this medium will be a powerful tool in nerve-muscle tissue engineering, discovering the molecules which trigger the switching between different myosin heavy chain proteins during muscle development, dissecting the molecules involved in synapse formation at the neuromuscular junction, and for applications in diseases such as ALS, muscular dystrophy, other diseases, and injuries of spinal cord.
